Proscia Concentriq

Pathology AI Platform for Precision Medicine

Proscia Concentriq is the leading computational pathology platform that powers precision medicine workflows from drug discovery through clinical diagnosis. Trusted by 16 of the top 20 pharmaceutical companies and over 4,000 hospitals and clinics globally, Concentriq delivers AI-native intelligence to pathologists and scientists making critical decisions in healthcare and life sciences.

Purpose-Built for Clinical and Research Excellence

The platform serves two primary audiences with specialized solutions:

• Clinical Labs: An immersive, operationally intelligent review experience for diagnostic pathologists at the point of review, enabling primary diagnosis workflows • Life Sciences: Comprehensive tools for biomarker research, clinical trials, and companion diagnostics development, turning tissue samples into actionable insights

Key Capabilities

Concentriq's fifth generation architecture incorporates:

• AI-native platform design with clinically and scientifically grounded intelligence built into core workflows • Digital pathology image management handling 12M+ cases annually • Support for 30,000+ studies from discovery through clinical trials • Interoperable AI applications and native AI features for research and diagnostic workflows • Enterprise-grade scalability proven across global pharma and healthcare organizations

Industry Recognition and Trust

Named the highest-rated digital pathology platform by KLAS in both the United States and Europe for 2026, Concentriq achieved 100% customer satisfaction with all users indicating they would purchase again. The platform has become essential infrastructure for organizations navigating the complexity of targeted therapies and biomarker-driven patient selection.

Regulatory Compliance

Concentriq AP-Dx is FDA-cleared for primary diagnosis in the United States and CE-marked under EU IVDR. Research configurations (Concentriq AP and Concentriq LS) are available for research use only, supporting drug development and scientific investigation workflows.

What Sets Concentriq Apart

Unlike platforms with AI capabilities bolted on, Concentriq is built from the ground up as an AI-native system, enabling pathologists to focus on high-judgment interpretation while helping scientists accelerate from early signals to confident program decisions. The platform addresses the full continuum of precision medicine, from understanding disease mechanisms to selecting the right patients for targeted treatments.